Application of ML models to predict postoperative outcomes in renal cell carcinoma.
Atulya Aman Khosla(Baptist Hospital of Miami), Karan Jatwani(Roswell Park Comprehensive Cancer Center), Muni Rubens(Florida International University), Akshit Chitkara(Thomas Jefferson University), Venkataraghavan Ramamoorthy(Baptist Health South Florida), Rohan Garje(Baptist Hospital of Miami), Ishmael Jaiyesimi(Beaumont Hospital, Royal Oak), Manas Pustake(Texas Tech University), Nitya Batra(Jacksonville College), Anshul Saxena(Baptist Hospital of Miami), Mohammad Arfat Ganiyani(Baptist Hospital of Miami)
Cited by 0
Related Papers
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|116
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Impact of Telemedicine on Mortality, Length of Stay, and Cost Among Patients in Progressive Care Units: Experience From a Large Healthcare System*
|Critical Care Medicine|2018|89
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80